Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation

C Main, L Bojke, S Griffin, G Norman, M Barbieri, L Mather, D Stark, S Palmer, R Riemsma

Research output: Contribution to journalLiterature reviewpeer-review

Original languageEnglish
Pages (from-to)1+
Number of pages129
JournalHealth technology assessment
Issue number9
Publication statusPublished - Mar 2006

Cite this